MARENGO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 332
AS - Asia 133
OC - Oceania 4
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 965
Nazione #
US - Stati Uniti d'America 483
SE - Svezia 90
CN - Cina 78
IT - Italia 48
DE - Germania 47
FR - Francia 30
FI - Finlandia 27
IE - Irlanda 26
AT - Austria 21
SG - Singapore 16
KR - Corea 13
BE - Belgio 11
GB - Regno Unito 9
VN - Vietnam 9
HK - Hong Kong 8
CA - Canada 7
PL - Polonia 7
UA - Ucraina 6
AU - Australia 3
EG - Egitto 3
RO - Romania 3
BR - Brasile 2
ID - Indonesia 2
IN - India 2
PH - Filippine 2
RU - Federazione Russa 2
TH - Thailandia 2
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
Totale 965
Città #
Ann Arbor 88
Chandler 87
Beijing 58
Villeurbanne 27
Dublin 26
Dearborn 24
Vienna 21
Ashburn 18
Medford 16
Nyköping 13
Torino 13
Brussels 11
Houston 11
Princeton 10
Singapore 10
Boardman 9
Fairfield 9
Pisa 9
Wilmington 9
Woodbridge 9
New York 8
Fremont 7
Ottawa 7
Munich 6
Dong Ket 5
Jacksonville 5
Turin 5
Düsseldorf 4
Falls Church 4
Seattle 4
Warsaw 4
Bucharest 3
Edgewood 3
Helsinki 3
Krakow 3
Nanchang 3
Redwood City 3
Al Minya 2
Bangkok Noi 2
Caloocan City 2
Central 2
Duisburg 2
Genoa 2
Hanoi 2
Jakarta 2
Kunming 2
Lancaster 2
League City 2
Livorno 2
Los Angeles 2
Nanjing 2
New Malden 2
Norwalk 2
Redmond 2
Santa Clara 2
Seongnam-si 2
Taranto 2
West Lafayette 2
Adelaide 1
Bengaluru 1
Bologna 1
Boulder 1
Brno 1
Budapest 1
Cambridge 1
Central District 1
Centro 1
Chengdu 1
Christchurch 1
Copenhagen 1
Duncan 1
Durham 1
Hull 1
Jamaica Plain 1
Jinan 1
Lisbon 1
Nuremberg 1
Nürnberg 1
Orange 1
Parma 1
Phoenix 1
Pinerolo 1
Provo 1
Pune 1
Quzhou 1
Rome 1
Seoul 1
Shanghai 1
Sorso 1
Sydney 1
Tappahannock 1
Toledo 1
Torrazza 1
Votuporanga 1
Vreden 1
Westchester 1
Wuhan 1
Totale 636
Nome #
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 193
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile. 129
Increased epicardial fat and early signs of impaired diastolic and systolic left ventricular function in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic Fatty Liver Disease 128
Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with Non Alcoholic Fatty Liver Disease independent of diabetes, hypertension and dyslipidemia 121
Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis 93
Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander. 81
Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic fatty Liver Disease 77
Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: do clinicians adhere to current guidelines? 63
Letter: renal effects of Tenofovir in Adefovir-dipivoxil experienced HBV patients. 60
Prediction of EVs presence by calculated risk scores in B-viral cirrhosis. 58
Totale 1.003
Categoria #
all - tutte 2.629
article - articoli 0
book - libri 0
conference - conferenze 1.262
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 3 3 13 3 23 12 3 7 21 2 4
2020/2021125 9 5 4 14 22 15 2 0 14 8 13 19
2021/2022114 2 5 5 13 4 4 4 4 7 12 30 24
2022/2023228 22 32 7 30 16 50 13 14 29 3 6 6
2023/2024125 9 22 9 12 17 19 5 10 0 3 7 12
2024/202517 8 9 0 0 0 0 0 0 0 0 0 0
Totale 1.003